血清IL-34与社区获得性肺炎患者的严重程度和预后之间的长度关联
Fei Tang1, Xue-Feng Hou2, Yu Cheng1
1Department of Interventional Pulmonology and Endoscopic Diagnosis and Treatment Center, Anhui Chest Hospital, Hefei, Anhui, 230022, China.
Respiratory investigation
|January 13, 2024
概括
在社区获得性肺炎 (CAP) 患者中,血清干白素-34 (IL-34) 含量升高,与疾病严重程度有关. 较高的IL-34水平预示着更糟糕的结果,这表明它有可能成为CAP的预后生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 介素-34 (IL-34),一种细胞因子和CSF-1R连接体,与炎症性疾病有关.
- 在社区获得性肺炎 (CAP) 中IL-34的作用尚不清楚.
- 这项研究调查了IL-34与CAP严重程度和预后的关联.
研究的目的:
- 评估血清IL-34水平与CAP严重程度之间的关系.
- 评估IL-34作为CAP患者预后的预测指标.
- 探索IL-34与CAP中的炎症标志物的相关性.
主要方法:
- 酶相关免疫吸收试验 (ELISA) 用于测量血清IL-34和炎症性细胞因子.
- 收集了来自CAP患者和健康志愿者的数据,包括临床信息.
- 进行了纵向分析,以追踪住院期间的结果.
主要成果:
- 在CAP患者中,血清IL-34水平明显高于健康对照组.
- 升高的IL-34与CAP严重性得分 (PSI,SMART-COP) 和炎症类细胞因子正相关.
- 接受较高的IL-34水平增加了机械通风和死亡的风险,在预测死亡方面表现优于严重程度得分.
结论:
- 血清IL-34显示了与CAP严重程度和不良预后的剂量反应相关性.
- IL-34在CAP的发展和进步中发挥着重要作用.
- 血清IL-34是预测疾病进展和CAP中不良结果的潜在生物标志物.
相关概念视频
01:30Pneumonia III: Complications and Assessment
227
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
227
01:30Pneumonia I: Introduction
239
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239
01:28Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331